×

ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy

TYSONS CORNER, Va., April 1, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.

The pharmacy has generated a total of $642,267 in revenue over the last six weeks since ScripsAmerica entered an agreement to manage its operations in exchange for a significant percentage of its revenues. March's revenues give the pharmacy an annual run rate of $5.94 million.

"ScripsAmerica is very pleased to report that our new specialty pharmacy generated very strong revenues in March and we anticipate its monthly prescription sales to experience steady growth. This represents a new and consistent monthly revenue stream that will increase Scrips' shareholder value in addition to our pharmaceutical distribution equity ventures and sales of RapiMed," commented ScripsAmerica's CEO, Bob Schneiderman.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: 888-959-7095 ir@sealpointconsulting.comSource:ScripsAmerica, Inc.